Journal of Yeungnam Medical Science

Review article

Medical Informatics
Digital therapeutics in Korea: current status, challenges, and future directions – a narrative review: Hee Jun Shin, Ik Tae Cho, Wan Suk Choi, Hong Rae Kim, Min Bong Kang, Won Jong Yang; J Yeungnam Med Sci. 2025;42:8. Published online November 18, 2024; DOI: https://doi.org/10.12701/jyms.2024.01004

23,896 View
230 Download
4 Web of Science
7 Crossref

Digital therapeutics (DTx) are emerging as a transformative innovation in healthcare offering evidence-based digital interventions for the treatment, management, and prevention of various diseases and disorders. In Korea, DTx have gained significant attention as potential solutions to the increasing burden of chronic diseases and mental health conditions. However, the Korean DTx market faces several challenges that hinder its widespread adoption and integration into the national healthcare system. This study provides a comprehensive analysis of the current state of the DTx market in Korea, identifies the key challenges impeding its growth, and proposes strategies for overcoming these obstacles. This study utilized a literature review and market analysis approach to examine the latest research, industry reports, and regulatory documents related to DTx. The analysis focused on three primary areas: (1) the current regulatory landscape, (2) technological advancements and challenges, and (3) economic and commercial factors influencing DTx adoption in Korea. A comparative analysis of global regulatory practices was also conducted to identify best practices. The findings revealed that while Korea has made significant strides in supporting DTx development, the market remains in its early stages. The key challenges include underdeveloped regulatory frameworks, issues with data quality and security, and a lack of established reimbursement pathways. We recommend developing tailored regulatory frameworks for DTx, enhancing policy support for small and medium-sized enterprises involved in DTx development, and increasing investments in technological infrastructure. By addressing these challenges, Korea could position itself as a leader in the global DTx market, delivering innovative and effective treatments to enhance patient care and outcomes.

Citations

Citations to this article as recorded by

Strategies to Increase Patients’ Adherence to Digital Therapeutics for Musculoskeletal Diseases: A Narrative Review
Myeonghwan Bang, Jung Hyun Park
Yonsei Medical Journal.2026;[Epub] CrossRef
Applying a mobile intervention for chronic insomnia in routine care: Study protocol for a multicenter randomized controlled trial
Daa Un Moon, Jeonghun Kim, Jeyoung Hannah Sun, Yujin Lee
Internet Interventions.2025; 41: 100848. CrossRef
Digital Therapeutics for Cognitive Impairment: Exploring Innovations, Challenges, and Future Prospects
Grace Yuange Zang, Keqin Rao, Jing Wu, Yunhan He, Yi Tang, Leiyu Shi
Journal of Medical Internet Research.2025; 27: e73689. CrossRef
Cluster-based quality analysis of mobile health applications based on health behavior theories
Kyong Hee Park, Jeongwon Heo, Hyewon Jang, Youngju Lee, Seoyeon Kim, Hye-Ryoung Kim
Korean Journal of Health Education and Promotion.2025; 42(3): 53. CrossRef
Perceptions and Acceptance of Digital Mental Health Therapeutics Among Psychiatrists
Dahye Jeon, Mose Hwang, Sungmin Son, Taehui Kim, Kyuho Jeong, Aeri Shim, YeonJoo Nam
Journal of Korean Neuropsychiatric Association.2025; 64(4): 306. CrossRef
Musculoskeletal Digital Therapeutics and Digital Health Rehabilitation: A Global Paradigm Shift in Orthopedic Care
Youn Kyu Lee, Eun-Ji Yoon, Tae Hyung Kim, Jong-Ick Kim, Jong-Ho Kim
Journal of Clinical Medicine.2025; 14(23): 8467. CrossRef
Developing and Evaluating Guidelines to Prevent Overdependence on Digital Therapeutics in Children and Adolescents: Randomized Controlled Trial
Euno Kim, Hajae Jeon, Junghan Lee, Hyangkyeong Oh, Meelim Kim, Jaeyong Shin, Eunjoo Kim
Journal of Medical Internet Research.2025; 27: e69248. CrossRef

First
Prev
Page of 1
Next
Last

Search